Due to the large number of NPC patients with very high seroprevalence of EBV VCA IgA and EA/D IgA antibodies, the 483 NPC patients (mean age, 48.7 ± 13.0 years; median age, 49 years) were excluded from the total number of patients and the rest of the patients without NPC (non-NPC) were re-arranged into different age groups, as presented in Table 2. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.